Amanote Research

Amanote Research

    RegisterSign In

A Comparison of Apremilast Monotherapy and Combination Therapy for Psoriatic Arthritis in a Real Life Setting: Data From the Leeds Combined Psoriatic Service

Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2019.02.014
Full Text
Open PDF
Abstract

Available in full text

Categories
Dermatology
Date

June 1, 2019

Authors
Giuseppina AbignanoNafisa FadlMira MerashliClaire VandeveldeJane FreestonDennis McGonagleHelena Marzo-Ortega
Publisher

Elsevier BV


Related search

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Rheumatology and Therapy
2014English

AB0761 the Biologic Therapy Use for Enthesitis as a Predictor of Psoriatic Arthritis in Psoriatic Patients

2017English

Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2019English

SAT0353 Geographical Differences in Psoriatic Arthritis: A Transatlantic Comparison

2018English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy